trending Market Intelligence /marketintelligence/en/news-insights/trending/5rLMsOJ_BgXU-KiBzU3z0A2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

NanoString Technologies closes $68.3M common stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


NanoString Technologies closes $68.3M common stock offering

NanoString Technologies Inc. closed an underwritten public offering of 3,175,000 of its common shares priced at $23.00 apiece.

Stocks sold include the 675,000 additional common shares underwriters bought as part of their overallotment option.

Seattle-based NanoString said in March 25 news release that it raised about $68.3 million in net proceeds from the offering.

The life sciences tools and services company plans to use the net proceeds of the offering for working capital and general corporate purposes.

J.P. Morgan, UBS Investment Bank and Cowen acted as joint book-running managers for the offering. Baird acted as lead manager for the offering.

Concurrently, NanoString's stockholder Clarus Lifesciences II LP, a private equity fund, sold 2 million of the company's common shares at $23.00 apiece. NanoString will not receive any proceeds from the sale of the common shares by Clarus.

NanoString Technologies is a provider of life science tools for translational research and molecular diagnostic products. The company offers the nCounter Analysis System, an automated, multiapplication, digital detection and counting system.